Free Trial
ASX:VBS

Vectus Biosystems (VBS) Stock Price, News & Analysis

About Vectus Biosystems Stock (ASX:VBS)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
N/A
Market Capitalization
A$4.15 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive VBS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Vectus Biosystems and its competitors with MarketBeat's FREE daily newsletter.

VBS Stock News Headlines

Everyone’s watching Nvidia right now. Here’s why I’m excited.
So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal with Saudi Arabia to power its new AI empire 🤯 We’re talking about hundreds of thousands of chips, including their latest Grace Blackwell supercomputer.
See More Headlines

Industry, Sector and Symbol

Stock Exchange
ASX
Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
ASX:VBS
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-A$2.34 million
Net Margins
-205.34%
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
A$1.14 million
Price / Cash Flow
N/A
Book Value
A$0.03 per share
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
A$4.15 million
Optionable
Not Optionable
Beta
0.87
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for July 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report

This page (ASX:VBS) was last updated on 7/8/2025 by MarketBeat.com Staff
From Our Partners